Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: an 8-month prospective study.
Diabetes Research and Clinical Practice（2019）
摘要
•Treatment with exenatide showed cardiovascular safety.•An improvement on atherosclerosis surrogate markers was found.•The changes were independent of glucometabolic control.
更多查看译文
关键词
Exenatide,Diabetes mellitus, type 2,Atherosclerosis,Carotid intima-media thickness,Cardiovascular diseases
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要